analyst
RA
NASDAQ · RARE
Ultragenyx Pharmaceutical Inc.
Healthcare · Biotechnology
$14.77
Down-$0.55 (-3.72%)
Updated Sep 25, 2026, 6:16 PM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.49B
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $12.73 – $39.89
- Volume
- 3.49M
- Avg. volume
- 1.5M
Price performance
RARE price history
1M range · 20 trading sessions · Daily adjusted prices
RARE closed at $14.77 after 20 trading sessions, down 43.75% for the selected period.
- Last close
- $14.77
- Period change
- -43.75%
- Period low
- $12.88
- Period high
- $26.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $14.73 | $14.87 | $14.545 | $14.77 | 3.49M |
| Sep 23, 2026 | $15.40 | $15.4979 | $14.54 | $14.88 | 5.71M |
| Sep 22, 2026 | $14.78 | $16.12 | $14.475 | $15.615 | 8.13M |
| Sep 21, 2026 | $14.58 | $15.01 | $14.275 | $14.65 | 5.27M |
| Sep 18, 2026 | $14.79 | $15.07 | $14.07 | $14.51 | 13.34M |
| Sep 17, 2026 | $13.22 | $14.575 | $13.20 | $14.50 | 12.43M |
| Sep 16, 2026 | $13.07 | $13.22 | $12.73 | $12.88 | 5.03M |
| Sep 15, 2026 | $13.56 | $13.59 | $12.88 | $13.07 | 5.66M |
| Sep 14, 2026 | $14.44 | $14.4444 | $13.60 | $13.61 | 5.93M |
| Sep 11, 2026 | $14.43 | $14.70 | $14.13 | $14.30 | 3.25M |
| Sep 10, 2026 | $14.25 | $14.44 | $13.95 | $14.40 | 3.67M |
| Sep 9, 2026 | $14.77 | $15.1947 | $14.27 | $14.31 | 4.58M |
| Sep 8, 2026 | $15.097 | $15.25 | $14.6283 | $14.88 | 5.93M |
| Sep 4, 2026 | $15.475 | $16.0799 | $15.23 | $15.30 | 11.49M |
| Sep 3, 2026 | $14.00 | $15.00 | $13.81 | $14.85 | 27.16M |
| Sep 2, 2026 | $25.96 | $26.795 | $25.57 | $26.53 | 7.17M |
| Sep 1, 2026 | $25.215 | $25.85 | $25.105 | $25.81 | 1.87M |
| Aug 31, 2026 | $25.45 | $25.90 | $24.7308 | $25.21 | 1.93M |
| Aug 28, 2026 | $26.54 | $26.73 | $25.37 | $25.61 | 1.61M |
| Aug 27, 2026 | $26.38 | $26.56 | $25.83 | $26.26 | 1.14M |
Latest RARE news
The latest Smart Investors Daily articles mentioning RARE.
Stock researchCompany · Forecast
Loading stock research…